Is Carbocysteine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Carbocysteine, including RHINATHIOL EXPECTORANT CARBOCISTEINE 5% SYRUP FOR ADULT (500 mg/ml, Syrup, SAR 13.60); RHINATHIOL SYRUP 20MG-ML CHILDREN (20 mg/ml, Syrup, SAR 9.30).

Active substance

Carbocysteine

SFDA 4

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
RHINATHIOL EXPECTORANT CARBOCISTEINE 5% SYRUP FOR ADULT	500 mg/ml	Syrup · Oral use	125 Bottle	SAR 13.60	NCE · Prescription	Opella Healthcare France	Valid
RHINATHIOL SYRUP 20MG-ML CHILDREN	20 mg/ml	Syrup · Oral use	125 Bottle	SAR 9.30	NCE · Prescription	Opella Healthcare France	Valid
BRONCHOBOS 375 MG CAPSULES	375 mg	Capsule · Oral use	30 Blister	SAR 12.15	Generic · Prescription	BOSNALIJEK PHARMACEUTICAL	Withdrawn by MAH · Not Marketed
RHINATHIOL CAPS 375MG	375 mg	Capsule · Oral use	30 Blister	SAR 15.15	NCE · OTC	sanofi-aventis	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.